For instance, the justification provided for OBP2 was that “OSBP2 mutations have been associated with age-related macular degeneration, a condition that affects the retina.”, or for another gene: “FAM46C mutations are associated with multiple myeloma, a type of cancer of the plasma cells.” And while these statements are factual (e.g. [33]), they do not pertain to erythroid cells or erythropoiesis. This evidence concerns the gene OSBP2 and cancer.